How effective is Relpax for Complicated Migraine? (a real world drug study)

Summary:

Overall ratings: 3.5/5
Long term ratings: 3.3/5

This is a phase IV clinical study of how effective Relpax (eletriptan hydrobromide) is for Complicated migraine and for what kind of people. The study is created by eHealthMe from 4 Relpax users and is updated continuously.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Complicated migraine?

Complicated migraine (weakness, loss of vision, or difficulty speaking in addition to the headache) is found to be associated with 9 drugs and 107 conditions by eHealthMe. Check the latest studies of Complicated migraine.


On Jul, 15, 2026

4 people are studied for taking Relpax in Complicated migraine

Overall effectiveness (number of people):

Does Relpax work for your Complicated migraine (overall)?

Long term (1+ years) effectiveness (number of people):

Does Relpax work for your Complicated migraine (long term)?

Relpax effectiveness for Complicated migraine (number of people):

Overall:
  • not at all: 0
  • somewhat: 0
  • moderate: 2
  • high: 2
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 2
  • high: 1
  • very high: 0

Gender of people who take Relpax for Complicated migraine *:

  • female: 75 %
  • male: 25 %

Age of people who take Relpax for Complicated migraine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 25 %
  • 60+: 25 %

Who find Relpax more effective for Complicated Migraine?

Gender of people who take Relpax for Complicated migraine *:

  • female: 50 %
  • male: 50 %

Age of people who take Relpax for Complicated migraine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 50 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Relpax?

- You can start a phase IV clinical trial to monitor Relpax safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on eletriptan hydrobromide (the active ingredients of Relpax) and Relpax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: